Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury

Journal of Neuroscience

Volumn 21, Issue 1, 2001, Pages 92-97

  Xu, Jan ^a   Kim, Gyeong Moon ^a   Ahmed, S Hinan ^a   Xu, Jinming ^a   Yan, Ping ^b   Xu, Xiao Ming ^b   Hsu, Chung Y ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Methylprednisolone; NF B; Protease; RU486; Transc ription factor

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; GELATINASE B; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; METHYLPREDNISOLONE; MIFEPRISTONE; PROTEIN C JUN; PROTEIN FOS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FEMALE; FOOD AND DRUG ADMINISTRATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY; TRANSACTIVATION; WESTERN BLOTTING;

EID: 0035144802     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-01-00092.2001     Document Type: Article

References (58)

1. Proteinases and extracellular matrix remodeling
2. Expression of c-fos and c-jun family genes after focal cerebral ischemia
3. Pathology of experimental spinal cord trauma. I. The necrotic lesion as a function of vascular injury
4. Pathology of experimental spinal cord trauma. II. Ultrastructure of axons and myelin
5. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms
6. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
7. Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat
8. MASCIS evaluation of open field locomotor scores: Effects of experience and teamwork on reliability. Multicenter animal spinal cord injury study
9. Traumatic spinal cord injury induces nuclear factor-kappaB activation
10. Macrophages and inflammatory damage in spinal cord injury
11. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: An absolute requirement for transcription factor N F-kappa B
12. Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts
13. Methylprednisolone in the management of acute spinal cord injuries
14. Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha
15. Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the antiinflammatory action of glucocorticoids
16. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes
17. Suppression of postischemic hippocampal nerve growth factor expression by a c-fos antisense oligodeoxynucleotide
18. Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract
19. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
20. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord
21. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases
22. A monitored contusion model of spinal cord injury in the rat
23. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities
24. Acute effects of intravenous glucocorticoid pretreatment on the in vitro peroxidation of cat spinal cord tissue
25. Involvement of an intercellular adhesion molecule 1-dependent pathway in the pathogenesis of secondary changes after spinal cord injury in rats
26. Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins
27. Methylprednisolone in spinal cord injury: The possible mechanism of action
28. Vascular permeability in experimental spinal cord injury
29. Immunocytochemical analysis of hormone mediated nuclear translocation of wild type and mutant glucocorticoid receptors
30. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone
31. AP-1 function and regulation
32. Receptor-mediated effects of glucocorticoids on inflammation: Enhancement of the inflammatory response with a glucocorticoid antagonist
33. Endogenous glucocorticoids modulate neutrophil migration and synovial P-selectin but not neutrophil phagocytic or oxidative function in experimental arthritis
34. Metastatic potential correlates with enzymatic degradation of basement membrane collagen
35. Suppression of ischemia-induced fos expression and AP-1 activity by an antisense oligodeoxynucleotide to c-fos mRNA
36. Neuronal and glial apoptosis after traumatic spinal cord injury
37. Neuronophagia by leukocytes in experimental spinal cord injury
38. Steroids and spinal cord injury: Revisiting the NASCIS 2 and NASCIS 3 trials
39. Concept of autoimmunity following spinal cord injury - Possible roles for t lymphocytes in the traumatized central nervous system
40. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats
41. Interleukin 1 stimulation of collagenase production by cultured fibroblasts
42. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor
43. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines
44. Characterization of mechanisms involved in transrepression of N F-kappa B by activated glucocorticoid receptors
45. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor
46. The sense of antisense fos oligonucleotides
47. Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts
48. Gelatinase B: Structure, regulation, and function
49. AP-1: One switch for many signals
50. Leukotriene B4 and polymorphonuclear cell infiltration in spinal cord injury
51. Protective effect of methylprednisolone on vascular injury in rat spinal cord injury
52. Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats
53. Glucocorticoid receptor expression in the spinal cord after traumatic injury in adult rats
54. Increased expression of c-fos mRNA and AP-1 transcription factors after cortical impact injury in rats
55. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction
56. Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by N F-kappa B and AP-1
57. Matrix metalloproteinases and diseases of the CNS
58. Experimental analysis of progressive necrosis after spinal cord trauma in the rat: Etiological role of the inflammatory response